Matthew T. David - Jan 14, 2023 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Chief Financial Officer
Signature
/s/ Matthew T David
Stock symbol
CRMD
Transactions as of
Jan 14, 2023
Transactions value $
$0
Form type
4
Date filed
1/18/2023, 05:53 PM
Previous filing
Feb 23, 2022
Next filing
Jan 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRMD Common Stock 3.15K Jan 14, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +125K $0.00 125K Jan 14, 2023 Common Stock 125K $4.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 1/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.